Physician profile
Mark Figgie
NPI 1811910953
$221,456.60
in general payments reported to CMS, 2019-2025
18 companies · $882 in 2025
The $882 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,146 · 2020: $25K · 2021: $177K · 2022: $8,706 · 2023: $1,197 · 2024: $51.84 · 2025: $882.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,652 · Travel and Lodging: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,652.27 |
| Travel and Lodging | $477.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, Lp | $156,161.04 | 2021 | |
| Limacorporate S.P.A. | $38,514.12 | 2019-2022 | |
| Lima USA, INC. | $15,624.18 | 2019-2022 | |
| Wishbone Medical INC. | $9,955.38 | 2021-2023 | Anterior Spine |
| Suvon Surgical LLC | $515.09 | 2025 | |
| Zimmer Biomet Holdings, INC. | $169.53 | 2025 | Persona, Totalshield |
| Arthrex, INC. | $114.05 | 2025 | |
| Biogen, INC. | $93.31 | 2021 | |
| Spinal Surgical Strategies, INC. | $66.00 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $61.70 | 2022-2025 | Cuvitru |
| Linkbio Corp | $51.84 | 2024 | |
| Kinamed, INC. | $48.32 | 2019 | |
| Lundbeck LLC | $23.82 | 2021 | |
| Csl Behring | $16.62 | 2022 | |
| Horizon Therapeutics Plc | $15.19 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $13.63 | 2020 | |
| Fidia Pharma USA INC. | $12.78 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$45,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Figgie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.